GLP-1 medications were originally developed to treat type 2 diabetes
A provider should help determine which option fits your goals and safety needs
Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
Instead, gently swirl the vial or roll it between your palms
Olson, S.E
Common side effects include: Nausea (most common, usually improves over time) Vomiting or diarrhea Constipation Rarely, pancreatitis or gallbladder issues For a deeper dive into risks and what to watch for, see our dedicated guide: GLP-1 Side Effects Explained by Doctors